New MRI Data from Asterias' Ongoing SCiStar Clinical Study Indicates AST-OPC1 Cells Prevent Formation of Damaging Lesion Cavities in Patients Suffering Severe Spinal Cord Injury

MRI scans are consistent with durable engraftment of AST-OPC1 cells in the damaged area of the spinal cord and show the potential of AST-OPC1 to reduce spinal cord tissue deterioration after severe spinal cord injury These disease-modifying aspects of A... Regenerative Medicine, Neurosurgery Asterias Biotherapeutics, AST-OPC1, SCiStar, spinal cord injury, stem cell
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news